GlassScriptPhysician profile
Vy Nguyen
NPI 1851925291
$9,219.44
in general payments reported to CMS, 2019-2025
49 companies · $544 in 2025
The $544 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,671 · 2022: $2,052 · 2023: $2,645 · 2024: $1,307 · 2025: $544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,488 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,487.83 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,159.28 | 2021-2023 | |
| Tris Pharma INC | $787.45 | 2023-2025 | Dyanavel Xr, Onyda Xr |
| Astrazeneca Pharmaceuticals LP | $777.04 | 2021-2023 | Farxiga, Breztri |
| Lilly USA, LLC | $631.88 | 2021-2023 | Mounjaro, Jardiance, Emgality |
| Novo Nordisk INC | $629.09 | 2021-2024 | Rybelsus, Ozempic |
| Abiomed | $492.62 | 2024 | Impella |
| Glaxosmithkline, LLC. | $483.48 | 2021-2023 | Arexvy, Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $432.29 | 2021-2023 | |
| Amgen INC. | $373.44 | 2021-2025 | Evenity, Otezla, Repatha |
| Nestle Healthcare Nutrition INC. | $280.96 | 2021-2023 | |
| Scilex Pharmaceuticals INC. | $261.17 | 2021-2023 | Ztlido |
| Lundbeck LLC | $239.63 | 2024-2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $208.63 | 2021-2023 | Jardiance |
| Amarin Pharma, INC. | $196.02 | 2021-2023 | |
| Gilead Sciences, INC. | $190.17 | 2021-2024 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vy Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.